The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Surgeons in San Francisco begin a 6-way kidney transplant chain involving 12 patients that began with a single altruistic donor.
(Reuters) — Doctors at a San Francisco hospital began an unusual series of kidney transplants yesterday with 6 living donors providing organs to 6 patients in a chain that began with a woman described as an altruistic donor unrelated to any of the recipients.
Here's a look at some of the top legal news stories for medical device companies this week: Diabetes: Tandem plans $60m offering; OrthoSensor pulls in $17m funding round; EndoChoice raises $57m for Fuse endoscope; InspireMD looks to raise $14m for CGuard stent launch
A California state jury hits Johnson & Johnson with a $5.7 million verdict in the 1st trial involving its Abbrevo pelvic mesh, and a federal appeals court upholds its win in the 1st bellwether case against its Ethicon subsidiary.